Pharmaceutical distributor RA Williams Distributors Limited is positioning its eyecare segment as another driver of growth for the business, following a recent expansion of its ophthalmic portfolio.

Building on a 14-year partnership with Aristopharma Limited, the company has introduced three new products — Drylief, Neotear and Hypomer Gel — aimed at expanding patient access to advanced ocular care while strengthening its presence in a specialist, prescriber-driven market.

CEO Audley Reid, responding to questions from the Jamaica Observer this week, said the latest expansion aligns with the company’s long-standing focus on delivering high-quality pharmaceutical solutions while connecting global innovation with local health-care needs.

“Fourteen years ago, we entered the eyecare market with Aristobet-N, and our mission remains the same. As a pharmacist-led organisation, this expansion into ocular health is not just a product launch; it is a strategic move to capture high-value market share in a segment with strong patient retention and consistent demand,” he further said to the Business Observer, while noting that introduction of the new Aristopharma lubricants will allow his company to penetrate a prescriber-driven niche.

The product range which targets rising demand for dry eye and ocular surface therapies, is driven in part by increased screen time and conditions such as computer vision syndrome. By offering tiered treatment options — from mild irritation to chronic cases — the latest additions are expected to give clinicians greater flexibility in patient care.

Following disruptions from hurricane-related impacts and broader macroeconomic challenges that weighed on performance in previous quarters, Reid said the timing of the ophthalmic expansion should support incremental revenue growth over the next 18 to 24 months, based on consistent demand within the category.

“By diversifying our portfolio into the ‘wellness and lifestyle’ space, we aim to capture a broader share of consumer spending while insulating revenue against fluctuations in any single sector,” he said.

Reversing losses at the end of the first quarter ended January 31, 2026, RA Williams reported a profit of $33.5 million — double that of the prior-year period earned on higher revenues of $541.9 million.

As the distributor broadens its reach beyond traditional pharmaceuticals and taps into wellness and preventive care, it earlier this year partnered with dermatologist Dr Romario Thomas to distribute his skincare brand, Absolut Skin. Since then, the company has also intensified efforts to place more products in large retail chains.

“We are moving our brands into some of Jamaica’s largest retail footprints to meet consumers where they shop most frequently. We’re currently in the final onboarding stage for Absolut Skin at MegaMart, with products expected to be on shelves by the end of this week. This move complements our existing presence in the pharmacy network as we push to bring clinical-grade skincare to a wider supermarket demographic,” Reid said.

In addition to newer products, other established lines such as Sir Henry Turmeric Immunity Shots have been gaining traction in warehouse clubs, convenience outlets and gas station networks across the island.

“Our retail push has been allowing us to tap into the growing ‘on-the-go’ wellness trend across multiple networks,” Reid stated.

As the company pursues a dual-track growth strategy—balancing its pharmaceutical base with an expanding wellness portfolio — Reid said management will continue to target products that address gaps in chronic disease control while scaling local brands with national distribution potential.

“A major component of our future growth is our commitment to local innovation. Lines like Sir Henry and Absolut Skin are world-class Jamaican brands, and we see ourselves as the bridge bringing them to a wider national audience. Whether it is a life-saving medication in a pharmacy or a wellness shot in a supermarket, we are ensuring that R A Williams is present wherever the Jamaican consumer prioritises their health,” Reid said.

“By combining specialised medical treatments with high-velocity wellness products, we are building a diversified portfolio that is resilient, accessible and uniquely Jamaican.”

REID… as a pharmacist-led organisation, this expansion into ocular health is not just a product launch; it is a strategic move to capture high-value market share in a segment with strong patient retention and consistent demand